Logo image of AXR

AMREP CORP (AXR) Stock Fundamental Analysis

NYSE:AXR - New York Stock Exchange, Inc. - US0321591051 - Common Stock - Currency: USD

23.65  -0.03 (-0.13%)

Fundamental Rating

7

AXR gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. AXR gets an excellent profitability rating and is at the same time showing great financial health properties. AXR is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make AXR suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year AXR was profitable.
AXR had a positive operating cash flow in the past year.
AXR had positive earnings in 4 of the past 5 years.
AXR had a positive operating cash flow in each of the past 5 years.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

With an excellent Return On Assets value of 10.06%, AXR belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
With an excellent Return On Equity value of 10.29%, AXR belongs to the best of the industry, outperforming 89.23% of the companies in the same industry.
AXR's Return On Invested Capital of 8.35% is amongst the best of the industry. AXR outperforms 95.38% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AXR is significantly above the industry average of 5.47%.
Industry RankSector Rank
ROA 10.06%
ROE 10.29%
ROIC 8.35%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

With an excellent Profit Margin value of 22.34%, AXR belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
In the last couple of years the Profit Margin of AXR has grown nicely.
The Operating Margin of AXR (22.81%) is better than 86.15% of its industry peers.
In the last couple of years the Operating Margin of AXR has declined.
AXR has a Gross Margin of 35.18%. This is in the better half of the industry: AXR outperforms 64.62% of its industry peers.
AXR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 22.81%
PM (TTM) 22.34%
GM 35.18%
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), AXR is creating some value.
The number of shares outstanding for AXR has been reduced compared to 1 year ago.
Compared to 5 years ago, AXR has less shares outstanding
Compared to 1 year ago, AXR has a worse debt to assets ratio.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

AXR has an Altman-Z score of 28.09. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
AXR has a better Altman-Z score (28.09) than 96.92% of its industry peers.
The Debt to FCF ratio of AXR is 0.00, which is an excellent value as it means it would take AXR, only 0.00 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.00, AXR belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that AXR is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, AXR belongs to the best of the industry, outperforming 86.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 28.09
ROIC/WACC0.93
WACC8.99%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.3 Liquidity

AXR has a Current Ratio of 34.79. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AXR (34.79) is better than 98.46% of its industry peers.
A Quick Ratio of 12.59 indicates that AXR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 12.59, AXR belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 34.79
Quick Ratio 12.59
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

8

3. Growth

3.1 Past

AXR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 475.10%, which is quite impressive.
Measured over the past years, AXR shows a very strong growth in Earnings Per Share. The EPS has been growing by 47.37% on average per year.
The Revenue has grown by 30.36% in the past year. This is a very strong growth!
AXR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.04% yearly.
EPS 1Y (TTM)475.1%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%566.5%
Revenue 1Y (TTM)30.36%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%-40.74%

3.2 Future

The Earnings Per Share is expected to grow by 16.07% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.69% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2Y17.49%
EPS Next 3Y15.53%
EPS Next 5Y16.07%
Revenue Next YearN/A
Revenue Next 2Y3367.11%
Revenue Next 3Y991.44%
Revenue Next 5Y8.69%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 2028 2029 20B 40B 60B
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.77, which indicates a very decent valuation of AXR.
Based on the Price/Earnings ratio, AXR is valued cheaply inside the industry as 90.77% of the companies are valued more expensively.
AXR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
Industry RankSector Rank
PE 9.77
Fwd PE N/A
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXR is valued cheaply inside the industry as 98.46% of the companies are valued more expensively.
93.85% of the companies in the same industry are more expensive than AXR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.74
EV/EBITDA 6.59
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

AXR has an outstanding profitability rating, which may justify a higher PE ratio.
AXR's earnings are expected to grow with 15.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)0.21
EPS Next 2Y17.49%
EPS Next 3Y15.53%

0

5. Dividend

5.1 Amount

AXR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMREP CORP

NYSE:AXR (7/11/2025, 8:04:00 PM)

23.65

-0.03 (-0.13%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-17 2025-03-17
Earnings (Next)07-29 2025-07-29
Inst Owners43.85%
Inst Owner Change0%
Ins Owners44.9%
Ins Owner Change0%
Market Cap125.11M
Analysts0
Price TargetN/A
Short Float %1.33%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.77
Fwd PE N/A
P/S 2.16
P/FCF 8.74
P/OCF 8.57
P/B 0.99
P/tB 0.99
EV/EBITDA 6.59
EPS(TTM)2.42
EY10.23%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.71
FCFY11.44%
OCF(TTM)2.76
OCFY11.67%
SpS10.97
BVpS23.81
TBVpS23.81
PEG (NY)N/A
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 10.06%
ROE 10.29%
ROCE 10.51%
ROIC 8.35%
ROICexc 11.81%
ROICexgc 11.87%
OM 22.81%
PM (TTM) 22.34%
GM 35.18%
FCFM 24.66%
ROA(3y)13.67%
ROA(5y)8.5%
ROE(3y)14.81%
ROE(5y)9.15%
ROIC(3y)11.51%
ROIC(5y)N/A
ROICexc(3y)14.28%
ROICexc(5y)N/A
ROICexgc(3y)14.32%
ROICexgc(5y)N/A
ROCE(3y)14.5%
ROCE(5y)N/A
ROICexcg growth 3Y-13.41%
ROICexcg growth 5YN/A
ROICexc growth 3Y-13.43%
ROICexc growth 5YN/A
OM growth 3Y-12.96%
OM growth 5YN/A
PM growth 3Y-10.97%
PM growth 5Y2.13%
GM growth 3Y-7.98%
GM growth 5Y29.24%
F-Score8
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 169.77%
Cap/Sales 0.5%
Interest Coverage 250
Cash Conversion 108.87%
Profit Quality 110.39%
Current Ratio 34.79
Quick Ratio 12.59
Altman-Z 28.09
F-Score8
WACC8.99%
ROIC/WACC0.93
Cap/Depr(3y)361.42%
Cap/Depr(5y)217.58%
Cap/Sales(3y)1.12%
Cap/Sales(5y)0.68%
Profit Quality(3y)90.43%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)475.1%
EPS 3Y9.61%
EPS 5Y47.37%
EPS Q2Q%566.5%
EPS Next YN/A
EPS Next 2Y17.49%
EPS Next 3Y15.53%
EPS Next 5Y16.07%
Revenue 1Y (TTM)30.36%
Revenue growth 3Y8.61%
Revenue growth 5Y32.04%
Sales Q2Q%-40.74%
Revenue Next YearN/A
Revenue Next 2Y3367.11%
Revenue Next 3Y991.44%
Revenue Next 5Y8.69%
EBIT growth 1Y77.7%
EBIT growth 3Y-5.47%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y1046.89%
EBIT Next 5Y15.15%
FCF growth 1Y14.53%
FCF growth 3Y-6.63%
FCF growth 5Y77.63%
OCF growth 1Y15.46%
OCF growth 3Y-5.29%
OCF growth 5Y78.57%